Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy

Figure 6

The docking model diagram of the active ingredient of the drug and the core target molecule: (a–d) the action mode of TP53 and quercetin, luteolin, kaempferol, and formononetin; (e–h) the action mode of STAT3 and quercetin, luteolin, kaempferol, and formononetin; (i–l) the action mode of MAPK1 and quercetin, luteolin, kaempferol, and formononetin; (m–p) the action mode of JUN and quercetin, luteolin, kaempferol, and formononetin.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)